Your browser doesn't support javascript.
loading
Multimodal Deep Learning Improves Recurrence Risk Prediction in Pediatric Low-Grade Gliomas.
Mahootiha, Maryamalsadat; Tak, Divyanshu; Ye, Zezhong; Zapaishchykova, Anna; Likitlersuang, Jirapat; Climent Pardo, Juan Carlos; Boyd, Aidan; Vajapeyam, Sridhar; Chopra, Rishi; Prabhu, Sanjay P; Liu, Kevin X; Elhalawani, Hesham; Nabavizadeh, Ali; Familiar, Ariana; Mueller, Sabine; Aerts, Hugo J W L; Bandopadhayay, Pratiti; Ligon, Keith L; Haas-Kogan, Daphne; Poussaint, Tina Y; Qadir, Hemin Ali; Balasingham, Ilangko; Kann, Benjamin H.
Affiliation
  • Mahootiha M; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Tak D; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Ye Z; The Intervention Centre, Oslo University Hospital, Oslo, Norway.
  • Zapaishchykova A; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Likitlersuang J; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Climent Pardo JC; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Boyd A; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Vajapeyam S; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Chopra R; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Prabhu SP; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Liu KX; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Elhalawani H; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Nabavizadeh A; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Familiar A; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Mueller S; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Aerts HJWL; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bandopadhayay P; Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Ligon KL; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Haas-Kogan D; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Poussaint TY; Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Qadir HA; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Balasingham I; Department of Radiation Oncology, Dana-Farber Cancer Institute | Brigham and Women's Hospital | Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Kann BH; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Neuro Oncol ; 2024 Aug 30.
Article in En | MEDLINE | ID: mdl-39211987
ABSTRACT

BACKGROUND:

Postoperative recurrence risk for pediatric low-grade gliomas (pLGGs) is challenging to predict by conventional clinical, radiographic, and genomic factors. We investigated if deep learning of MRI tumor features could improve postoperative pLGG risk stratification.

METHODS:

We used pre-trained deep learning (DL) tool designed for pLGG segmentation to extract pLGG imaging features from preoperative T2-weighted MRI from patients who underwent surgery (DL-MRI features). Patients were pooled from two institutions Dana Farber/Boston Children's Hospital (DF/BCH) and the Children's Brain Tumor Network (CBTN). We trained three DL logistic hazard models to predict postoperative event-free survival (EFS) probabilities with 1) clinical features, 2) DL-MRI features, and 3) multimodal (clinical and DL-MRI features). We evaluated the models with a time-dependent Concordance Index (Ctd) and risk group stratification with Kaplan Meier plots and log-rank tests. We developed an automated pipeline integrating pLGG segmentation and EFS prediction with the best model.

RESULTS:

Of the 396 patients analyzed (median follow-up 85 months, range 1.5-329 months), 214 (54%) underwent gross total resection and 110 (28%) recurred. The multimodal model improved EFS prediction compared to the DL-MRI and clinical models (Ctd 0.85 (95% CI 0.81-0.93), 0.79 (95% CI 0.70-0.88), and 0.72 (95% CI 0.57-0.77), respectively). The multimodal model improved risk-group stratification (3-year EFS for predicted high-risk 31% versus low-risk 92%, p<0.0001).

CONCLUSIONS:

DL extracts imaging features that can inform postoperative recurrence prediction for pLGG. Multimodal DL improves postoperative risk stratification for pLGG and may guide postoperative decision-making. Larger, multicenter training data may be needed to improve model generalizability.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido